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Abstract CCN3 expression was observed in a broad
variety of tissues from the early stage of development.
However, a kind of loss of function in mice (CCN3 del
VWC domain -/-) demonstrated mild abnormality, which
indicates that CCN3 may not be critical for the normal
embryogenesis as a single gene. The importance of CCN3
in bone marrow environment becomes to be recognized by
the studies of hematopoietic stem cells and Chronic
Myeloid Leukemia cells. CCN3 expression in bone marrow
has been denied by several investigations, but we found
CCN3 positive stromal and hematopoietic cells at bone
extremities with a new antibody although they are a very
few populations. We investigated the expression pattern of
CCN3 in the cultured bone marrow derived mesenchymal
stem cells and found its preference for osteogenic differen-
tiation. From the analyses of in vitro experiment using an
osteogenic mesenchymal stem cell line, Kusa-A1, we found
that CCN3 downregulates osteogenesis by two different
pathways; suppression of BMP and stimulation of Notch.
Secreted CCN3 from Kusa cells inhibited the differentiation
of osteoblasts in separate culture, which indicates the
paracrine manner of CCN3 activity. CCN3 may also affect
the extracellular environment of the niche for hematopoietic
stem cells.
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Introduction
CCN3 (Nov, Nephroblastoma overexpressed) was originally
identified as a gene that is responsible for nephroblastoma
in chicken induced by the infection of a retrovirus (Soret et
al. 1989) and now classified as a member of CCN family of
genes (Brigstock et al. 2003). CCN is a Cysteine-rich small
secretory protein that interacts with various extracellular
and transmembrane proteins. In chicken embryogenesis,
CCN3 expression starts from the early stage (Hamburger
and Hamilton (HH) Stage 5) (Katsube et al. 2001). Initial
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complex (notochord and floor plate), which guides the
polarized differentiation of midline structure from the
ventral side, such as neural tube, vertebra, and visceral
endoderm. Since this body patterning stage, CCN3 expres-
sion is observed in a wide variety of mesodermal and
ectodermal cells such as osteoblasts, myoblasts, chondro-
blasts, epithelial cells and neuroblasts. Even in adult,
several mesodermal tissues maintain the expression of
CCN3. Like CCN3, CCN1 and CCN2 expression was
observed in mesodermal tissues from the early stage
development (Katsube et al. 2009), but their pattern is not
identical. CCN1 expression during development is observed
in extraembryonic tissues such as the chorion and the
allantois during the placenta formation (Mo et al. 2002).
CCN2 expression was observed in the developing noto-
chord (Chiou et al. 2006; Erwin 2008), but its pattern is not
precisely the same as CCN3.
The broad distribution of CCN3 in embryonic tissues let
us expect drastic deformities in its knockout mice, but a
recent investigation about a practical CCN3 knockout mice
(CCN3 del VWC domain -/-) revealed that they are viable
even after the birth (Heath et al. 2008). Although several
mild changes in skeletogenesis and joint formation,
myocardiopathy and lens degeneration of eye were found,
whole morphogenesis is not much affected. CCN3 is not
likely to be really critical as a single gene in the normal step
of embryogenesis although there is an argument if this KO
mice really represent a true loss of function of CCN3
(Perbal 2007). This fact is rather surprising because
dysmorphic changes in both CCN1 and CCN2 knockout
mice were apparent in the vasculogenesis and osteo/
chondrogenesis, which lead to the lethal hemorrhage or
skeletal abnormalities before or just after the birth(Mo et al.
2002) (Ivkovic et al. 2003).
The role of CCN3 in adult tissues remains elucidated,
but several investigations suggest the role of CCN3 in
hematopoiesis. Chronic myeloid leukemia (CML) occurs
by a chromosomal translocation of t(9;22)(q34;q11), which
creates a fused protein between BCR and ABL, a
constitutively active form of tyrosine kinase. Before the
stage of acute blastic crisis, the growth of CML cells
requires the niche environment of hematopoiesis although
they partially obtain the cell autonomous proliferation
ability. The mechanism of acute blastic crisis is not yet
fully understood, but initial potency of CML is believed to
be due to the constitutive kinase activation of BCR-ABL
gene product. Down-regulation of CCN3 was induced as a
direct consequence of BCR-ABL kinase activity in FDCP-
Mix primitive hematopoietic stem cells (McCallum et al.
2006). Administration of a tyrosine kinase inhibitor
(Imatinib) upregulates CCN3 expression and transfection
of CCN3 inhibits proliferation and decreases clonogenic
potential of BCR-ABL (+) CML cells. From these results, it
may be possible to hypothesize that CCN3 directly
regulates the proliferation and differentiation of myeloid
precursor cells in the niche of normal hematopoiesis. In
fact, transient upregulation of CCN3 is essential for the
development of hematopoietic stem cells derived from the
umbilical cord vein or of FDCP-Mix cells (Gupta et al.
2007). Particularly, primitive stage of hematopoietic cells
(CD34 (+)) is sensitive for CCN3 expression. Down-
regulation by siRNA of CCN3 abrogates their differentia-
tion ability and upregulation of CCN3 either by CCN3 gene
transfection or protein administration promotes their differ-
entiation and proliferation. These investigations were done
in culture in vitro of hematopoietic cells without the effect
of stroma, in which self-regulation of hematopoietic cells is
discussed for CCN3 expression. But it may be more
possible that the neighboring cells to hematopoietic stem
cells commit the regulation of CCN3 constructing the niche
environment. In this issue, we focus on the role of CCN3 in
the bone marrow environment.
Materials and methods
Whole mount in situ hybridization
See the references for the detailed information about the
used probes (chicken CCN3 (Katsube et al. 2001), chicken
Sonic Hedgehog (Watanabe and Nakamura 2000), chicken
Serrate1 (Sakamoto et al. 1998)). The digoxigenin-labeled
cRNA antisense and sense probes were prepared using
linearized plasmid DNA according to the manufacturer’s
protocol (Roche Diagnostics). Embryonic stage was deter-
mined by Hamburger and Hamilton staging (Hamburger
1992). Expression of each gene was visualized with
antisense probes verifying the background coloration with
sense probes (negative control). Coloration was stopped
before the background staining started. The chick embryos
were dissected and fixed in 4% paraformaldehyde/phos-
phate-buffered saline (PBS). Whole mount in situ hybrid-
ization was performed in accordance with the protocol
described in the reference (Papalopulu et al. 1991). Tissue
section was made with 7 μm thickness after dehydration
and embedding in paraffin.
Expression profiling
Mouse bone marrow derived mesenchymal stem cells
were cultured with α-modified minimum essential medi-
um (α-MEM) containing 10% fetal bovine serum (FBS).
In semiconfluent stage, total RNA was extracted with
Trizol (Invirogen) and approximately 1 μg of total RNA
was reversetranscribed to cDNA by Superscript II
136 K.-i. Katsube et al.(Invitrogen). Detailed information about the analysis of
genechip using cDNA is supplied by manufacturer’s
home page (Affymetrix, http://www.affymetrix.com/
index.affx).
Anti CCN3 antibody
Rabbit polyclonal antibody against murine CCN3 was
raised by three different synthetic epitope peptides (amino
acid residue position; 83–95; CDRSADPNNQTGI-coNH2,
246–260; CEQEPEEVTDKKGKK-coNH2, 334–348;
CPQNNEAFLQDLELK-coNH2). These amino acid
sequences are well conserved among species. Raised
antisera are purified with the peptide of 334–348;
CPQNNEAFLQDLELK-coNH2. In this study, pre-
absorption experiment of the antibody was performed with
this peptide.
Immunohistochemistry
EDTA decalcified mouse adult (8 weeks after birth) femoral
bone is embedded in paraffin. Tissue section was made by
5 μm thickness. The sections are deparaffinated by xylene
and hydrated in PBS. Tissue section was incubated with
anti-CCN3 antibody (diluted in 1:1000) overnight at 4°C.
Antibody detection was performed by Envision rabbit
antibody system. Coloration was performed with 3, 3’-
diaminobenzidine and nuclear counterstain was done with
Hematoxylin.
Western blot analysis
The cells were lysed with TNTE buffer (100 mM Tris-Cl
pH 7.6, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100).
The samples were boiled in Laemmli loading buffer for
2 min, applied to 10% SDS-PAGE, and electroblotted
onto Hybond-ECL nitrocellulose membrane (Amersham
Biosciences). The proteins were identified using the
raised anti CCN3 antibody and Envision rabbit antibody
system (Dako-Cytomation). The chemiluminescent imag-
ing was performed with ECL advanced western blot
detection kit (Amersham Biosciences). Anti CCN1 anti-
body was raised in rabbit (Mo et al. 2002). Anti CCN2
antibody was purchased (rabbit anti-CTGF, Torrey Pines
Biomedical). Anti CCN3 antibody is the same as used in
immunohistochemistry.
Alkaline phosphatase induction in C2C12 cells in separate
coculture
Kusa-A1 cells were cultured in α-MEM containing 10%
FBS. C2C12 cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 20% FBS. CCN3 and
CCN3 ΔCT were transfected to Kusa-A1 by Flp-In system
(Invitrogen) using FuGENE 6 Transfection Reagent (Roche
Diagnostics). Kusa cells stably expressing CCN3 or CCN3
ΔCT were selected with 200 μg/ml Hygromycin (WAKO)
and isolated several clones with single colony isolation.
C2C12 cells are inoculated into the dish at semiconfluency.
Recombinant human BMP2 (Osteogenetics) was adminis-
tered at 500 ng/ml for one day to initialize the osteoblastic
differentiation of C2C12. Then, the BMP2 containing
culture media were removed and rinsed once with
DMEM. Separate coculture started with Kusa-A1 cells
using a membrane culture insert (Becton Dickinson).
Separate coculture was maintained in DMEM containing
10% FBS for three days. Alkaline phosphatase (ALP)
positive cells were visualized using NitroBlueTetrazolium
and 5-Bromo-4-Chloro-3-Indolylphosphate-5-Toluidine
salt after the fixation.
Results
Chicken CCN3 expression in embryonic
and extraembryonic tissues
Expression of CCN3 in axial structure becomes visible in
the presegmentation stage and reaches to the highest level
at the beginning of somitogenesis (HH stage 7, Fig. 1a).
Strong similarity between CCN3 and Sonic Hedgehog was
observed for the expression pattern in axial structure
(notochord and floor plate), in which the left–right
asymmetrical pattern in the node area is also conserved
(Fig. 1b). However, Sonic Hedgehog expression is slightly
broader than that of CCN3. Since CCN3 stimulates Notch
signaling (Sakamoto et al. 2002), we investigated the
expression of Notch signal genes. Among them, Serrate1,
a ligand of Notch is unique because its expression is
apparently a right deviated pattern in the node area
(Fig. 1c). Another Notch ligand, Delta1 shows a right
deviated pattern, but is more caudal area of the node
extending to the primitive streak (data not shown). The
expression of CCN3 in axial structure was followed by the
presomitic mesoderm although it is diminished (Sakamoto
et al. 2002).
There is accumulating evidence of CCN3 commitment to
hematopoiesis and therefore we investigated the CCN3
expression in extraembryonic tissues. Blood islands are
formed in the yolk sac mesodermal area just between the
visceral endodermal and ectodermal layers, which supply
the red blood cells at the primary stage. The cells in blood
islands are called hemangioblasts since they also differen-
tiate into the endothelial cells of extraembryonic blood
vessel structure. In chicken embryo, differentiating endo-
thelial cells in the ventral part of blood islands express
CCN3 and bone marrow 137CCN3 from the initial stage (Fig. 1e). Erythroblasts in the
center of blood islands (spherical cells in Fig. 1e) weakly
express CCN3 and their expression is mildly enhanced in
later stage (data not shown).
CCN3 and mouse bone marrow cells
The importance of bone marrow stromal cells as the niche
constituent for blood stem cells has been recognized from
the investigation of in vitro culture of hematopoietic cells
(Harigaya 1987). The stromal cells not only give the
microenvironment for the installation of hematopoietic
cells, but also produce several growth factors and mem-
brane associated proteins to maintain hematopoiesis
(Haylock and Nilsson 2005). In mammals and birds, bone
marrow is the main place for tertiary stage of hematopoi-
esis, but the precise histological locality of hematopoietic
stem cells has not been identified. In hematopoietic red
bone marrow, many osteoblasts and stromal cells colocalize
with hematopoietic cells, and histomorphologically, little
difference is observed in whole area. In 2003, two
independent research groups reported the precise locality
of hematopoietic stem cells(Calvi et al. 2003; Zhang et al.
2003), in which a few “osteoblastic” populations (not
termed as osteoblasts) in the bone extremities (endosteal
tissue near the epiphysis of long bone) are charged for the
niche formation. Also, the importance of several intercel-
lular regulatory molecules is demonstrated from these
reports such as Notch1/Jag1 and N-Cadherin. CCN3
expression in bone marrow has been expected from the
analysis of in vitro hematopoiesis, but genechip analyses
demonstrate that bone marrow tissue is empty for CCN3
expression (Refer to the web site of NCBI/Unigene; http://
www.ncbi.nlm.nih.gov/ with Nov (=CCN3)). It has been
difficult to detect the subtle expression of CCN3 by
commercially available antibodies and we raised a new
antibody in rabbit against mouse CCN3. We verified the
specificity of this antibody by western blot analysis
(Fig. 2a) using the protein extract of Kusa-A1. Raised
CCN3 antibody detected two bands (major 45kd and minor
16kd) while the preincubated antibody with the epitope
peptide had no specific bands. This CCN3 antibody was
applied to the immunohistochemistry of mouse adult bone
notochord
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Fig. 1 Expression of mRNA in early stage chicken embryo; CCN3
(a), Sonic Hedgehog (b) and Serrate1 (c) at the beginning stage of
somitogenesis (Hamburger and Hamilton (HH) Stage 7). Arrowheads
indicate Hensen’s node. Demonstrates the schematic view of tissue
organization at this stage (d). Expression of CCN3 mRNA in blood
islands of chicken extraembryonic tissue (HH stage 10) (e). Ventral
part of the endothelial precursor cells in blood islands is positive for
CCN3 expression. Coloration was stopped before the background
staining started in sense probes (negative control)
b
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Fig. 2 Confirmation of the
raised CCN3 antibody specifici-
ty (a) western blot analysis
using CCN3 antibody. Protein
extracts from Kusa-A1 were
lorded and incubated with non-
treated antibody or the antibody
pre-incubated with the epitope
peptide (b). CCN3 positive cells
in mouse adult femoral bone
marrow were detected with
non-treated antibody (c). No
positive cell is detected with the
antibody preincubated with the
epitope peptide
Fig. 3 CCN3 positive cells of
the bone marrow are observed in
the mouse femoral bone
extremities. Endothelial cells of
microvascular structure are
positive for CCN3. Several
surrounding cells (hematopoietic
and spindle-shaped stromal
cells) are also positive for
CCN3. On the while, diaphysis
bone marrow cells are negative
CCN3 and bone marrow 139marrow tissue (Fig. 2b). Endothelial cells and several cells
around the microvascular structure showed the immunore-
activity. On the while, the CCN3 antibody preincubated
with the epitope peptide showed no positive cells (Fig. 2c).
These CCN3 expressing cells exist only in the bone
extremities (Fig. 3); endosteal region near the epiphysis
including secondary ossifying center. Endothelial cells of
small blood vessels are positively stained with CCN3
antibody in the bone extremities. Around these vessels,
some spherical hematopoietic cells (including megakaryo-
cytes) and polygonal or spindle-shaped stromal cells are
also positive for CCN3. The spindle-shaped cells localized
just between the trabecular bone tissue and microvascular
structure. Some CCN3 positive spindle-shaped cells seem
to be loosely contacted each other.
CCN3 and cultured bone marrow derived mesenchymal
stem cells
To do the stable culture of hematopoietic cells, establish-
ment of stromal cell line is indispensable. Many attempts
have been done to get immortalized clones of stromal cells
(Umezawa et al. 1991). During the analyses of these
established cell lines, their own differentiation potential as
stem cells has come to be recognized (Umezawa et al.
1992). It is not surprising that they have the potential to
differentiate into osteoblasts or adipocytes since the bone
marrow cavity are filled with the trabecular bone and
adipose tissue in white bone marrow. But now it is known
that some of the bone marrow derived mesenchymal stem
cells differentiate into neurons or muscle cells, or even
some endodermal cells. From the tracing analysis using
genetic markers, some stromal cells in the bone marrow
seem to originate from the neural crest, which may explain
their pluripotency (Morikawa et al. 2009). This differenti-
ation potential is actually highlighted from the point of
view of their application to the human regeneration therapy,
but in vivo, these cells are quiescent in the usual state. A
few populations circulate in blood stream, which are seem
to be recruited to the injured area to restitute the tissue
organization. However, their proper regulatory mechanism
in reorganization is still not well understood although their
contribution is apparent.
Until now, a lot of clones of stem cells have been
identified from the bone-marrow stromal cells. Each cell
line of bone marrow stromal cells has different orientation
for differentiation (Kohyama et al. 2001). We chose four
independent clones of mouse stem cells and investigated
their expression property of CCN family of genes by gene-
chip analyses (Fig. 4). Examined cell lines are 9-15C, H123,
Kusa-A1 and Kusa-O. 9-15C is multipotential, which
includes osteogenic, chondrogenic, adipogenic, neurogenic,
and cardio-myogenic differentiation (Sharov et al. 2003). H-
123 is also multipotential, but strong preference for adipo-
genesis (Makino et al. 1999). Kusa-A1 and Kusa-O are sister
cell lines and both osteogenic (Umezawa et al. 1992).
However, Kusa-A1 has much stronger potential for osteo-
genesis and Kusa-O has relative tendency for adipogenic
differentiation (Kawashima et al. 2005; Allan et al. 2003).
Kusa-A1 also possesses the ability of neuronal differentia-
tion (Kohyama et al. 2001). Among CCN family of genes,
CCN3 is highly expressed in Kusa-A1 and Kusa-O (Fig. 4c).
On the while, CCN1 shows the tendency of high level
expression for adipogenic orientation (Kusa-O and H-123)
(Fig. 4a). Contrary to CCN1, CCN2 expression is suppressed
in adipogenic orientation (H-123 and Kusa A) (Fig. 4b). It
may be possible to hypothesize that CCN3 expression has
relatively high preference for osteogenic differentiation as
compared with other CCN family of genes. Western blot
analysis revealed that the protein level almost corresponds to
the mRNA level in each cell line (Fig. 4d).
CCN3 and osteogenic ability of bone marrow derived
mesenchymal stem cells
Endogenous CCN3 expression in Kusa-A1 is high in the
default state and moderately downregulated during the
induction of mineralization (Kawashima et al. 2005). It is
noteworthy that a relatively low osteogenic cell line of
Kusa, Kusa-O maintains the continuous high expression of
CCN3 (Kawashima et al. 2005). Therefore we investigated
the role of CCN3 in Kusa-A1 (Katsuki et al. 2008). For this
purpose, we created several deletion mutants of CCN3 to
investigate its role from the aspect of Notch signal. CT
domain binds to Notch extracellular domain and is
indispensable for the Notch signal activation.
Constitutive expression of CCN3 significantly down-
regulated osteogenesis of Kusa-A1, but did not affect its
neurogenesis. Anti-osteogenic activity of CCN3 was re-
duced by the deletion of the CT domain. This deletion
abrogates the upregulation of authentic Notch signal
downstream targets, Hes1 and particularly, Hey1. We also
demonstrated that CCN3 could downregulate cell prolifer-
ation of Kusa-A1. We found a specific upregulation of p21
among several cell cycle regulators and confirmed that
deletion of CT domain from CCN3 could cancel p21
upregulation, which suggests that CCN3 upregulates p21
through Notch signaling. In fact, inhibition of Notch signal
by gamma secretase inhibitor also downregulated the
CCN3 effect on p21 upregulation, strongly suggesting
CCN3 mainly employs Notch signal for p21 upregulation.
This finding is interesting from the point of view of the
Notch signal because p21 activation by Notch was reported
mainly in epithelial cells (Rangarajan et al. 2001). CCN3
seem to put default Kusa-A1 in a quiescent state suppress-
ing both osteogenesis and proliferation (Figs. 4 and 5).
140 K.-i. Katsube et al.The role of CCN3 in the microenvironment of bone
marrow is still not clear. The anti-osteogenetic ability of
CCN3 in osteoblast cell lines are demonstrated in vitro
culture (Minamizato et al. 2007; Parisi et al. 2006; Rydziel
et al. 2007), but CCN3 expression is under detectable in
most of the osteoblasts in vivo (Fig. 3). And also there has
been an argument that interaction of CCN3 with the relating
molecules is an intracellular event or an extracellular event
(cell-autonomous or non autonomous). It may be possible
that CCN3 is not expressed by osteoblasts themselves but
by other surrounding cells such as stromal cells. To clarify
these matters, we tried the separate coculture experiment
using Kusa-A1 and C2C12 that was initiated into osteo-
blastic differentiation (Fig. 6a). The induction of alkaline
phosphatase (ALP) in C2C12 was inhibited by secreted
CCN3 from Kusa-A1 (Fig. 6b). Kusa-LacZ transfected with
full length CCN3 by Flp-In vector clearly reduced the
number of ALP positive cells. On the while, Kusa-LacZ
transfected with CT deleted CCN3 moderately reduced the
number of ALP positive cells. These results indicate that
anti-osteogenetic activity of CCN3 is intercellularly medi-
ated probably by Notch stimulation and BMP suppression.
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Fig. 4 Expression profile of
CCN1 (a), CCN2 (b), and
CCN3 (c) mRNAs in four dif-
ferent mouse bone marrow de-
rived mesenchymal stem cell
lines. Top (1): 9-15c, right (2):
Kusa-O bottom (3): Kusa-A1,
left (4): H-123. Normalization of
relative expression level was
done by the comparison with a
set of house keeping genes in
the genechip of Affymetrix. All
quantitative analyses were done
by Affymetrix Gene Spring with
normalization with several
house-keeping genes. (d) West-
ern blot analysis with anti-
CCN1, CCN2 and CCN3. 1:
Kusa-A1, 2: Kusa-O, 3: 9-15C,
4: H-123, 5; MC3T3-E1
CCN3 and bone marrow 141Discussion
CCN3 expression is detected from the early stage of
embryogenesis including the hematopoiesis in the extraem-
bryonic tissue. Its expression in the ventral part of blood
islands is interesting because visceral endodermal cells of
yolk sac are considered to be essential for hemangiogenesis
(angiogenetic cell clustering), secreting Indian Hedgehog
(Byrd et al. 2002) and VEGF (Caprioli et al. 2001). Indian
Hedgehog expression is also observed in mesodermal cells
between visceral endoderm and embryonic ectoderm
(Grabel et al. 1998). High similarity in spatial distribution
pattern between CCN3 and the Hedgehog family gene is
also observed in Hensen’s node. Preliminary experiment
using the bead carrying recombinant CCN3 protein dem-
onstrated that CCN3 upregulates Sonic Hedgehog in the
nodal area (data not shown) during gastrulation. This
indicates that there exists the direct interaction for the
coexpression of CCN3 and Hedgehog gene family. Serrate1
expression in Hensen’s node is also interesting because
expression of Jag1, the murine equivalent of Serrate1 is
similar to that of CCN3 in bone marrow. We do not know
the significance of the mirror-imaged symmetrical expres-
sion pattern of CCN3 and Serrate1 in the node, but Notch
signal is reported to participate in left–right asymmetry
under the influence of calcium signal (Raya et al. 2003).
In adult mouse, a very few populations exhibit CCN3
expression in the extremity of bone marrow, whose area is
responsible for the stem cell niche of hematopoietic cells.
Previous investigations by gene chip analysis all failed to
detect CCN3 expression in bone marrow, but it may be due
to the limited locality of CCN3 positive cells (Bone
extremities are usually cut off to elute the bone marrow
cells.). As mentioned, distribution of CCN3 positive cells in
bone marrow is rather similar to that of Jag1 (=murine
Serrate1) positive cells although CCN3 positive cells are
much limited. CCN2 (CTGF) expression is previously
modified Kusa-A1
C2C12
-LacZ -CCN3 - ∆CT Kusa
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Fig. 6 CCN3 functions as a secreting inhibitor in alkaline phospha-
tase (ALP) induction ofC2C12 cells. a Schematic view of the separate
coculture experiment. Kusa-A1 and C2C12 cells were cultured in the
same dish, but separated by a thin membrane insert (Culture separate,
Becton Dickinson). The medium freely circulates, but no direct
contact between two separate cultures. b Effect of Kusa cells stably
transfected with CCN3 and its deleted form is measured by counting
ALP positive cells in C2C12 (cells/0.01 mm
2)
CCN3 effect in osteogenic bone 
marrow derived stem cells
mutual repression of osteogenesis
and proliferation via BMP (SMAD)
and Notch signaling (Hes/Hey,p21)
Fig. 5 Osteogenic mesenchymal stem cells negatively regulate
osteogenesis and proliferation by CCN3
CCN3
Blocking
BMP
Notch
Osteoblast
differentiation
Stimulation
Hematopoietic 
stem cell proliferation?
mesenchymal stromal cells
Notch
Stimulation
Jag1
Fig. 7 Scheme of a hypothetical role of CCN3 in the bone marrow
niche. CCN3 (yellow) suppresses the BMP (red) activity by direct
binding. On the while, CCN3 binds to Notch receptor, which results in
the signal stimulation. Notch signal stimulation is principal for the
maintenance of stem cell property, blocking the terminal differentia-
tion. CCN3 secreted by stromal stem cells modulates the growth and
differentiation of neighboring osteoblasts and hematopoietic stem cells
142 K.-i. Katsube et al.reported in the chondrocytes near the secondary ossifying
center (Oka et al. 2007), but there is no report about the
expression of CCN family of genes in the secondary
ossifying center itself.
As for cultured bone marrow-derived mesenchymal stem
c e l l s ,C C N 3e x p r e s s i o ni sh i g h l ym a i n t a i n e di nt h ed e f a u l t
state of an osteogenic cell line, Kusa-A1. In human bone
marrowderivedstemcells,theexpressionlevelofCCNfamily
was examined with regard to several orientation of differen-
tiation (adipogenesis, osteogenesis, chondrogenesis) (Schutze
et al.2005). From their investigation, CCN3 expression is not
detectable, but high expression of CCN1 and CCN2 was
observed in the default state. Their expression was down-
regulated in the course of differentiation, but there is no
particular correlation with differentiation orientation. Direct
evidence about the role of CCN in the human mesenchymal
stem cells is not confirmed from their investigation, but it is
hypothesized that CCN is a negative regulator of differenti-
ation. Another report demonstrated that the induction of
hepatocyte-like cells from human bone marrow derived stem
cells downregulated CCN4 and CCN5 expression (Shimo-
mura et al. 2007) while no significant change is observed in
CCN1, CCN2 and CCN3. They tried downregulation of
CCN4 or CCN5 by siRNA, which resulted in the promotion
of the hepatocyte-like differentiation. We observed that Kusa-
A1 downregulated endogenous CCN3 expression after the
induction of mineralization while low osteogenic Kusa-O
continuously upregulates CCN3 even after the treatment
(Kawashima et al. 2005). Continuous CCN3 upregulation in
Kusa-A1 downregulated the osteogenesis, but did not touch
its neurogenic potency (Katsuki et al. 2008). These facts may
indicate the CCN3 specifically affects the osteogenic differ-
entiation in murine bone marrow mesenchymal stem cells.
It may be intriguing to hypothesize that Kusa-A1 is a
core descendent of stem cell niche constituents of hemato-
poiesis because the stromal cells of hematopoietic niche are
“osteoblastic” (Calvi et al. 2003). Interaction of bone
marrow stromal cells with hematopoietic cells is critical as
they regulate the microenvironment of niche and maintain
the stemness and homing of hematopoietic stem cells. From
this point of view, p21 upregulation by CCN3 is interesting.
p21 is important not only for cell proliferation, but also
terminal differentiation of mesenchymal stem cells (van den
Bos et al. 1998). Also, stem cell maintenance of PML-RAR
activated hematopoietic cells requires p21 to prevent DNA
damage and excess proliferation (Viale et al. 2009). Recent
investigation of bone marrow niche demonstrates that
hematopoietic stem cells dynamically change their locality
with differentiation (Lo Celso et al. 2009). CCN3 may
regulate these complicated behaviors since it also affects
cell attachment and migration (Fukunaga-Kalabis et al.
2008). CCN3 expression suppresses not only the self-
osteogenic activity, but also the osteoblasts in separate
culture. This paracrine manner of CCN3 expression may
supply the bone cavity space enough to reside the niche
environment of hematopoiesis. The verification of the effect
of CCN3 in adult bone marrow would provide a new way
of thinking about hematopoiesis (Fig. 7). Analyses using
knockout mice of CCN3 are really necessary to give an
answer about this question.
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